title: [A probe using isotretinoin for treatment of poorly differentiated leukemia].
abstract: Isotretinoin (Roaccutane) was used in a patient with low differentiated cell leukemia. Poor general condition, very low blood cell count as well patient's lack of consent made chemotherapy impossible. The effect of isotretinoin treatment was full hematological and clinical remission. The general patient's condition did not require additional medication.
authors.affiliation: Katedry i Kliniki Chorób Wewnetrznych i Hematologii Akademii Medycznej w Warszawie.
authors.forename: W
authors.initials: W
authors.lastname: Duda-Król
authors.forename: I
authors.initials: I
authors.lastname: Jórasz
authors.forename: D
authors.initials: D
authors.lastname: Lewandowska
authors.forename: A
authors.initials: A
authors.lastname: Polubiec
mesh_terms: D000368:Aged; D006801:Humans; D015474:Isotretinoin / Q000627:therapeutic use*; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy*; D008297:Male; D012074:Remission Induction
chemical_list: D015474:Isotretinoin
vernacular_title: Próba zastosowania izotretynoiny w leczeniu białaczki niskozróznicowanokomórkowej.